Author

Peter Manu

Observed names: P Manu, P. Manu, PETER MANU, Peter Manu (7378025)

Observed institutions: Albert Einstein College of Medicine, Northwell Health, United States Department of Veterans Affairs, State University of New York, Feinstein Institute for Medical Research, Hofstra University, University of Connecticut, SUNY Upstate Medical University, Veterans Health Administration, Aalborg University Hospital, Maastricht University Medical Centre, Long Island Jewish Medical Center, Transilvania University of Brașov, European Graduate School of Neuroscience, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Wolters Kluwer Health, Zucker Hillside Hospital, Heinrich Heine University Düsseldorf, UConn Health

OpenAlex ID: A5113864549

Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis

2017 · Nicola Veronese, Emanuele Cereda, et al. · Ageing Research Reviews · 315

Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management

2015 · P. Manu, L. Dima, et al. · Acta Psychiatrica Scandinavica · 302

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

2006 · Christoph U. Correll, Anne M. Frederickson, et al. · Schizophrenia Research · 259

Termination of Clozapine Treatment Due to Medical Reasons

2013 · Jimmi Nielsen, Christoph U. Correll, et al. · The Journal of Clinical Psychiatry · 233

PDF

Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs

2006 · Christoph U. Correll, Anne M. Frederickson, et al. · The Journal of Clinical Psychiatry · 214

The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis

2016 · Brendon Stubbs, Davy Vancampfort, et al. · Journal of Affective Disorders · 202

The Mental Health of Patients With a Chief Complaint of Chronic Fatigue

1988 · P. Manu · Archives of Internal Medicine · 196

Inverse relationship between body mass index and mortality in older nursing home residents: a meta‐analysis of 19,538 elderly subjects

2015 · N. Veronese, E. Cereda, et al. · Obesity Reviews · 193

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second‐generation antipsychotics

2008 · Christoph U Correll, Anne M Frederickson, et al. · Bipolar Disorders · 158

The Frequency of the Chronic Fatigue Syndrome in Patients with Symptoms of Persistent Fatigue

1988 · Peter Manu, Thomas J. Lane, et al. · Annals of Internal Medicine · 155

When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature

2011 · Peter Manu, Deepak Sarpal, et al. · Schizophrenia Research · 152

Depression and somatization in the chronic fatigue syndrome

1991 · Thomas J. Lane, Peter Manu, et al. · The American Journal of Medicine · 141

The pharmacological management of metabolic syndrome

2018 · Julie Rask Larsen, Lorena Dima, et al. · Expert Review of Clinical Pharmacology · 121

Osteoporosis and fracture risk in people with schizophrenia

2012 · Taishiro Kishimoto, Marc De Hert, et al. · Current Opinion in Psychiatry · 121

Alpha-Delta Sleep in Patients With a Chief Complaint of Chronic Fatigue

1994 · PETER MANU, THOMAS J. LANE, et al. · Southern Medical Journal · 94

The Low Yield of Physical Examinations and Laboratory Investigations of Patients with Chronic Fatigue

1990 · Thomas J. Lane, Dale A. Matthews, et al. · The American Journal of the Medical Sciences · 93

Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients

2014 · Petru Ifteni, Christoph U. Correll, et al. · Schizophrenia Research · 92

Cost-Effective Screening for the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotic Medications

2005 · David Straker, Christoph U. Correll, et al. · American Journal of Psychiatry · 89

Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases

2018 · Peter Manu, Yevgeniya Lapitskaya, et al. · American Journal of Therapeutics · 80

Sudden Deaths in Psychiatric Patients

2011 · Peter Manu, John M. Kane, et al. · The Journal of Clinical Psychiatry · 80

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics

2020 · Simona Cernea, Lorena Dima, et al. · Drugs · 76

Depression among patients with a chief complaint of chronic fatigue

1989 · Peter Manu, Dale A. Matthews, et al. · Journal of Affective Disorders · 75

Markers of inflammation in schizophrenia: association vs. causation

2014 · Peter Manu, Christoph U. Correll, et al. · World Psychiatry · 59

PDF

Rapid clozapine titration in treatment-refractory bipolar disorder

2014 · Petru Ifteni, Christoph U. Correll, et al. · Journal of Affective Disorders · 55

Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia

2024 · Jurjen J. Luykx, Christoph U. Correll, et al. · JAMA Psychiatry · 54

PDF

Works count: 199

Citation count: 5,054

H-index: 36

I10-index: 71